Salarius Pharmaceuticals, Inc.
SLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6 | -$13 | -$32 | -$13 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $1 | $1 |
| Change in WC | $1 | -$1 | $2 | $2 |
| Other Non-Cash | $0 | $0 | $11 | -$0 |
| Operating Cash Flow | -$5 | -$13 | -$18 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$2 | $0 |
| Investing Cash Flow | $0 | $0 | -$2 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | $0 | -$0 |
| Stock Issued | $2 | $7 | $2 | $27 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $1 | $7 | $2 | $28 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$6 | -$17 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6 | $12 | $29 | $11 |
| End Cash | $2 | $6 | $12 | $29 |
| Free Cash Flow | -$5 | -$13 | -$19 | -$10 |